Vireo Growth (VREOF) Interest Coverage Ratio Growth (1y) (2021 - 2025)
Vireo Growth (VREOF) Interest Coverage Ratio Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -14.04% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 73.06% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -13.48% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -21.30% |
| 10 | Vireo Growth | - | - | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -77.60% |
| Jun 30, 2025 | -134.25% |
| Mar 31, 2025 | -51.77% |
| Dec 31, 2024 | -117.45% |
| Sep 30, 2024 | -29.49% |
| Jun 30, 2024 | 672.76% |
| Mar 31, 2024 | 956.44% |
| Dec 31, 2023 | 545.06% |
| Sep 30, 2023 | 2,285.50% |
| Jun 30, 2023 | -331.29% |
| Mar 31, 2023 | 103.06% |
| Dec 31, 2022 | 105.42% |
| Sep 30, 2022 | 98.15% |
| Jun 30, 2022 | 104.94% |
| Mar 31, 2022 | 64.28% |
| Dec 31, 2021 | 30.89% |
| Sep 30, 2021 | -1.39% |
| Jun 30, 2021 | 84.91% |
| Mar 31, 2021 | -5.47% |